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Abstract 
This thesis is concerned with a new class of drugs known as synthetic 
cathinones which overruns the drug markets in recent years as “legal highs” drugs, 
under different commercial names such as bath salts. All synthetic cathinone 
derivatives consist of a chiral center and usually sold out as a racemic mixture. Usually, 
one of the two enantiomers will have stronger central nervous system (CNS) 
stimulatory activity and the other one may have no significant CNS activity or 
addictive properties. A new sensitive and selective analytical method was developed 
for the simultaneous determination of ten synthetic cathinones enantiomers in spiked 
urine samples by gas chromatography coupled with tandem mass spectrometry GC-
NCI-MS/MS. Multiple reaction monitoring (MRM) mode was used for synthetic 
cathinones enantiomers identification and quantification in the presence of 3-MMC as 
an internal standard. The method adopted the indirect chiral separation of the synthetic 
cathinones enantiomers using menthylchloroformate (MCF) as the chiral derivatizing 
agent (CDA). 
Solid phase extraction (SPE) was used for urine samples clean up followed by 
derivatization step using MCF prior to gas chromatography analysis. The developed 
method was validated in terms of linearity, sensitivity, intraday and interday 
reproducibility, and recovery for all tested spiked urine samples. The method showed 
linearity and good correlation coefficient (R2) values higher than 0.98 within the tested 
range of 0.5 to 50 ppm for all synthetic cathinones enantiomers spiked in urine. The 
limits of quantitation in urine was 0.012 – 9.536 ppm and for limits of detection was 
0.004 – 3.147 ppm. For reproducibility, the mean value of coefficient of variance was 
below 12.3%. The mean recovery error was below 12%.  
The developed method can be used in forensic laboratories for separation and 
quantitative determination of synthetic cathinones enantiomers in urine samples. The 
separated and quantified enantiomers can provide information regarding the sources 
of these drugs and the raw materials used to create them to help law enforcement 
agencies with the drug tracking. 
 
Keywords: Synthetic cathinones, enantiomers, derivatization, chiral separation, 
menthylchloroformate, gas chromatography, tandem mass spectrometry (MS/MS). 
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 )cibarA ni( tcartsbA dna eltiT
تطوير طريقة تحليل جديدة لفصل وتحديد كميات التحضيرات الصناعية لمركبات 
 ستخدام جهاز الفصل الغازي ومطياف الكتلمصنعة في البول باالكاثينون ال
 صالملخ
بمركبات الكاثينون المصنعة  وحة بنوع جديد من العقاقير المعروفةهذه الأطر تختص
التي تعد طفرة جديدة في سوق المخدرات والعالم حيث تأخذ  )senonihtaC citehtnyS(
تحتوي جميع مركبات الكاثينون . )stlas htaB(مسميات تجارية مختلفة مثل "أملاح الاستحمام" 
ى شكل نها تصنع وتنشر في الأسواق علحيث إ )retnec larihC(المصنعة على مركز انطباقي 
في  )sremoitnanE(المقابلات الضوئية  إحدى. تشكل )erutxim cimecaR(مزيج راسيمي 
لها تأثير مركبات الكاثينون المصنعة وكغيرها من المركبات التي تحتوي على مركز انطباقي، 
تم تطوير وسيلة من المقابلات الضوئية الأخرى. البشري أكبر على نظام الأعصاب المركزي 
مقابلاتها مركبات الكاثينون المصنعة وتحليلية للفصل الانطباقي والتحليل الكمي لعدد عشر من 
تم التحقق من   .)SM-CG(في البول باستخدام جهاز الفصل الغازي ومطياف الكتل الضوئية 
وتقدير حساسية الطريقة  )ytiraenil(صحة وكفاءة طريقة التحليل المتبعة من خلال تقدير الخطية 
. )seirevocer(ل الاسترجاع ومعد )ytilibicudorper(ومعدل الاستعادة  )ytivitisnes(
للمقابلات الضوئية لمركبات الكاثينون غير المباشر الوسيلة طريقة الفصل الانطباقي تتبنى هذه 
 .)etamroforolhclyhtneM(مركب باستخدام المصنعة 
المقابلات الضوئية لمركبات الكاثينون في لجميع  نسبة الخطية من اهم النتائج المتحصل عليها
 635.9 – 210.0كان معدل الحد الكمي مليجرام / لتر في البول.   05 – 5.0التراكيزمعدل 
مليجرام / لتر. تم قياس إمكانية   741.3 – 400.0نسبة حد الكشف الادنى ومعدل  / لتر مليجرام
بنسبة نسبة الاسترجاع  وتم قياس %3.21التكرارية من نسبة فرق التباين وكانت النسبة اقل من 
 .%21كانت أقل من الخطأ و
المقابلات الضوئية  في فحصمن قبل المختبرات الجنائية يمكن استخدام هذه الوسيلة التحليلية 
لتوفير المعلومات الكافية حول مصدر هذه المخدرات في البول لمركبات الكاثينون المصنعة 
 تبع وتحديد مصدها.فيها ومكان تصنيعها وذلك لمساعدة رجال الأمن في ت والمواد الخام المستخدمة
 
الفصل الانطباقي، مركبات الكاثينون المصنعة، المقابلات الضوئية،  :مفاهيم البحث الرئيسية
  .الفصل الغازي، مطياف الكتل، اشتقاق
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Chapter 1: Introduction 
1.1 Overview 
Catha edulis, or Khat, is the name of a flowering shrub grown mainly in some 
parts of Africa and the Arabian Peninsula. Khat chewing plays a dominant role in 
everyday life style in some countries such as Yemen especially among men, where 
they consume it in social celebrations, and political meetings (Luqman, 1976). Khat is 
commonly chewed when fresh and sometimes it is left to dry and then consumed as 
stimulating beverage (Mwenda et al., 2004). Khat belongs to the Celastraceae family 
(the bitter-sweet family of plants) and it has different vernacular names based on its 
origin: Khat (or Qat) in English and in Arabic used in Yemen, and Jimaa or Chat in 
Ethiopia (Lemessa and Ababa, 2001).  
Many chemical studies on the components of Catha edulis showed that khat 
leaves consist of different chemicals such as: alkaloids, essential oils, amino acids, 
proteins, traces of vitamin C and iron (Al-hebshi and Skaug, 2005). The psycho-
stimulating properties of the khat is mainly caused by the presence of alkaloids. There 
are two major classes of alkaloids present in khat, the phenylalkylamines and the 
complex polyesters of polyhydroxylated dihydroagarofurans (cathedulins) (Crombie 
et al., 1990). Among the different classes of alkaloids in khat, (-) Cathinone is 
considered to be the most pharmacologically active component in khat leaves. (-) 
Cathinone belongs to the phenylalkylamines class of alkaloids found in khat and it was 
identified in late 20th century (Widler et al., 1994). It was found that cathinone is 
present with high concentration in young fresh leaves and its concentration vary (0.9-
3.3%) according to the origin of the khat tree. The active compound is very fragile and 
its concentration declines within few days after harvesting (Patel, 2009). The post 
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harvesting degradation of (-) Cathinone is mainly caused by sunlight exposure and 
heat. This degradation process of (-) Cathinone results in new less active compounds, 
which explains the need to chew fresh khat leaves immediately after harvesting 
(Valente et al., 2014). 
Cathinone, the psychoactive phenylalkylamines class of alkaloids found in 
khat has an amphetamine-like structure and stimulant effects. Amphetamine is a well-
known classical drug of abuse worldwide. Therefore, cathinone is considered to be a 
natural beta-keto amphetamine analogue found in the leaves of khat plant (Albals et 
al., 2016). Scheme 1 shows the chemical structure of cathinone and amphetamine. 
 
 
Scheme 1: Chemical Structure of Cathinone and Amphetamine 
Recent studies reported that khat is used by more than five million people every 
day, despite the variation among countries regarding the legality of the khat plant. The 
UN Convention on Psychotropic Substances in 1988, banned Cathinone, the natural 
stimulant found in khat, and it was listed as a Schedule I substance. Few authorities 
around the world are not familiar with khat and how to react to it in terms of 
categorization: should khat be treated as a drug, such as heroin and cannabis or be 
treated as tobacco and coffee? (Lamina, 2010). There are many reports on the health 
effects of khat-chewing such as malnutrition, liver cirrhosis, insomnia, pulmonary 
edema and other serious health effects (Al-hebshi and Skaug, 2005). Due to the 
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harmful effects of khat, many countries have treated khat as a controlled substance, 
including the United Arab Emirates, since 1995.  
Traditionally, the main psychoactive component of khat plant, cathinone is 
extracted during the chewing process of the fresh green leaves of khat. On the other 
hand, a new generation of modified cathinones have been synthesized and abused in 
different regions around the world known as New Designer Drugs (NDD) or Novel 
Psychoactive Drugs (NPD). This new strategy taken by drug dealers to sell their 
products as “novel psychoactive substances,” which contain at least one chemical 
substance that has similar biological effects as of the illegal natural cathinone allow 
them to offer legal alternative to the controlled substance. Those modified or 
synthesized cathinones are considered as “legal highs’ and usually labeled as “not for 
human consumption” under the name of “bath salts” and other commercial names to 
circumvent drug abuse legislation and to become widely spread. Synthetic cathinones 
or bath salts as known in the United States are mostly sold over the internet and in 
head shops as white powder, crystalline mixture or tablets. These compounds are 
usually snorted, smoked, injected intravenously or taken orally (German et al., 2014). 
Mephedrone (4-methylmethcathinone) is the first synthesized cathinone, became one 
of the most popular abused drugs in Europe since 2007 (Dargan et al., 2011). This 
cathinone derivative has produced many serious intoxications and some deaths in 
different countries. Due to the high concerns about the abuse of the cathinone-related 
derivatives and other novel psychoactive substances in Europe, the UK government 
and European Monitoring Center for Drugs and Drug Addiction (EMCDDA) banned 
all cathinone derivatives in April 2010 (Alremeithi et al., 2018).  
Most of the known synthetic cathinones have been derived from 
Methcathinone (Scheme 2), which had been developed in the former Soviet Union as 
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antidepressant in the 1930s and soon after around 1950s separately developed in the 
West as an appetite suppressant. The developed compound was never marketed due to 
its adverse reaction on human biological system and addictive potential (Spiller et al., 
2011). Nowadays, methcathinone is synthesized using over-the-counter drugs as 
precursor such as ephedrine and pseudoephedrine, followed by other reactions to 
produce other synthetic cathinones or methcathinone derivatives (Sikk and Taba, 
2015).  
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Scheme 2: Chemical Structures of Synthetic Cathinones Derived from 
Methcathinone 
(Katz et al., 2014) 
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Only in the early 21st century, the abuse of synthetic cathinones has been 
reported in different regions around the world, even though the first synthetic 
cathinone was developed 30 years before. This rise is fueled by the decrease in 
availability, purity, regulations, and high cost of other stimulant drugs of abuse, 
including 3,4-methylenedioxy-N-methylamphetamine (MDMA) and cocaine. The US 
and European drugs enforcement agencies indicate that the recent synthetic cathinone 
abuse involves mostly Methylenedioxypyrovalerone (MDPV) and Mephedrone, with 
less often implication with methylone, flephedrone, and naphydrone (Capriola, 2013).  
In 2009, in the UK, high percentage of night club attendees reported lifetime synthetic 
cathinones use especially mephedrone. Between August 2009 and August 2010 in 
Finland, 6% of 259 cases of driving under the influence were tested positive for 
MDPV. Moreover, about 2,656 calls have been received in 2012 by the American 
Poison Control Centers regarding exposure to synthetic cathinones, mainly in age 
group between 20 and 30-year old. Synthetic cathinones abuse resulted in interaction 
with law enforcement, emergency units’ engagement and implicated many users in 
critical conditions that can lead to death (Concheiro et al., 2013).  
Like amphetamine, cocaine and other stimulation-induced drugs, synthetic 
cathinones stimulate the central nervous system (CNS) by increasing synaptic 
concentration of serotonin, dopamine and norepinephrine. This increase of different 
neurotransmitters in CNS results in desired effects such as: increase in energy, 
sociability, and sexual desire. On the other hand, undesired effects such as: insomnia, 
increase heart rate, confusion, dizziness, prolonged panic attack and suicidal thoughts 
have been reported by users (Coppola and Mondola, 2012).  
Despite the fact that many of the existing synthetic cathinones have been 
already scheduled, clandestine laboratories constantly synthesizing new synthetic 
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cathinone derivatives to replace the outlawed new designed drugs as soon as legislation 
passes (German et al., 2014). In order to win this cat-and-mouse game between the 
law makers and clandestine laboratories, focused studies must be undertaken to 
investigate the neuropharmacology properties of these substances to prevent the abuse 
risks of novel psychoactive substances and help the law enforcement with the drug 
tracking.  
1.2 Statement of the Problem 
 In recent years, synthetic cathinones have spread across many regions around 
the world as an important class of the new designer drugs (NDD). This proliferation 
of synthetic cathinones has been associated with multiple criminal acts, intoxications 
and fatalities. From a forensic standpoint, this proliferation makes scientists in an 
ongoing challenge to develop new analytical methods for synthetic cathinones 
detection to keep up with the high pace of NDD trends. 
All synthetic cathinone derivatives consist of a chiral center and usually sold 
out as a racemic mixture. Usually, one of the two enantiomers will have stronger 
central nervous system (CNS) stimulatory activity and the other one may have no 
significant CNS activity or addictive properties (Mohr et al., 2012). Therefore, it is 
important to develop an analytical method capable of separating and detecting the 
synthetic cathinone enantiomers to provide information regarding the sources of these 
drugs and the raw materials used to create them to help law enforcement agencies with 
the drug tracking. 
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1.3 Objectives of the Study 
General Objective 
The general objective of this study was to develop and validate a sensitive and 
selective analytical method for qualitative and quantitative determination of synthetic 
cathinones enantiomers in spiked urine samples  
Specific Objectives 
1. To develop and validate a new enantioseparation method for synthetic 
cathinones in urine using Gas Chromatography-Tandem Mass Spectrometry 
(GC-MS/MS) with Negative Chemical Ionization (NCI) and Multiple Reaction 
Monitoring (MRM) mode. 
2. To test the feasibility of Menthylchloroformat (MCF) as derivatizing agent and 
its effect on the selectivity and sensitivity of the method. 
1.4 Approach 
This study involves the following tasks: 
Task 1: Developing the Gas Chromatography (GC) separation method for synthetic 
cathinones. 
Task 2: Developing the Mass Spectrometry (MS) detection of synthetic cathinones 
using Multiple Reaction Monitoring (MRM) mode. 
Task 3: Optimizing the GC-NCI-MSMS with the most suitable reagent gas. 
Task 4: Work with spiked urine samples, optimize sample preparation, cleanup and 
derivatization. 
Task 5: Method validation. 
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1.5 Relevant Literature 
1.5.1 Synthetic Cathinones and Chiral Compounds 
Chirality (also called enantiomers, dissymmetry or stereoisomerism) is a term 
used to describe objects that are mirror image of each other and therefore they cannot 
be superimposed. The origin of chiral term comes from the Greek word cheir, which 
means “handedness”. In chemistry, a molecule is called chiral when its mirror-image 
cannot be superimposed, and the two non-superimposed forms of chiral molecules are 
described as enantiomers. Looking at the human hands as an example, left and right 
hands are mirror-image or enantiomers. Enantiomers are usually formed when an atom 
like Carbon (Also Sulfur, Nitrogen and Phosphorus) that can act as an asymmetric 
center and contains four different substituents. The two enantiomers of a chiral 
compound can be classified as Dextrorotary (D-isomer) and Levorotary (L-isomer) or 
Rectus (R-isomer) and Sinister (S-isomer) based on their ability to rotate plane-
polarized light. Racemic mixture or “Racemate” refers to a mixture that has same 
concentration of the two enantiomers of a chiral compound. Even though the two 
enantiomers of a chiral compound may have similar chemical and physical properties, 
their biological activities usually vary (Nguyen et al., 2006). 
1.5.2 Chiral Compounds Separation 
Scientists in different fields have been recognizing the importance of chirality 
and enantioseparation of chiral compounds with respect to biological systems. Since 
our physiological environment is chiral, any two enantiomeric forms of a chiral 
compound may differ dramatically in their biological activities.  
There are two main approaches used within the pharmaceutical studies to 
separate chiral compounds: A direct method, where the enantiomers are separated 
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inside a column that has a chiral stationary phase (CSP) or as a chiral selector in a 
mobile phase with an achiral stationary phase. The other approach is based on the 
formation of two corresponding enantiomers by reacting the chiral compounds with 
chiral derivatizing agent (CDA) and separating them on an achiral stationary phase 
(Ilisz et al., 2008). The low cost, commercial availability of CDA and easier method 
development make the indirect approach an efficient technique for the 
enantioseparation of chiral compounds. Table 1 lists the advantages and disadvantages 
of both indirect and direct method.  
Table 1: Comparison of advantages and disadvantages of indirect and direct method 
(Ilisz et al., 2008) 
Indirect method Direct method 
Advantages: 
1. Good chromatographic properties 
of derivatives 
2. Predictable elution sequence  
3. Good fluorophoric or 
chromophoric properties of the 
reagent  
4. Low cost of achiral column  
5. Simple method development  
6. High selectivity  
1. The purity of the chiral selector is 
not critical 
2. Similar molar absorptivities of 
enantiomers  
3. Absence of racemization  
4. Simple preparation of analyte  
5. Temperature changes favorable  
6. Availability of preparative 
applications  
Disadvantages: 
1. The purity of the CDA is critical 
2. The molar absorptivity of the two 
enantiomers may differ 
3. Possibility of racemization  
4. Possibility of interferences 
5. Derivatization process may be 
time-consuming  
1. Small theoretical plate number for 
CSP  
2. Slow kinetics of desorption  
3. No universal column exists  
4. Possibility of interferences 
5. CSPs are sensitive to 
chromatographic condition  
6. High cost of chiral columns  
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1.5.2.1 Direct Chiral Separation  
In recent years, the method of direct chiral separation without the prior step of 
derivatization has gotten more attention from the analytical scientists. The direct 
method avoids the downside of the indirect method (Table 1), and usually simple and 
quicker in terms of sample preparation and analysis (Mehta, 1988). From the recently 
published papers, High performance liquid chromatography (HPLC) and Capillary 
electrophoresis (CE) are the two most used techniques for the direct chiral separation 
(Ward and Ward, 2010). These two techniques use chiral stationary phases (CSPs) 
such polysaccharide CSPs, ligand exchange CSPs, protein bound CSPs and cavity 
CSPs as chiral selectors (Sekhon, 2010).  
 High performance liquid chromatography (HPLC) is the most preferred 
method of direct chiral separation, and often uses polysaccharide CSPs. Although 
polysaccharide-based CSPs is the dominant and most used CSPs, macrocyclic and 
cyclodextrin-based CSPs applications are earning high attention lately (Ward and 
Ward, 2010). Designing and developing chiral stationary phases capable of efficient 
chiral recognition and separation is a key point of chiral chromatographic techniques. 
There are more than 100 CSPs have been prepared and commercialized for HPLC and 
other separation techniques (Yashima, 2001). In addition to the CSPs, other 
experimental variables such as ionic strength, pH, mobile phase (MP), buffer type, etc. 
may affect the chiral separation on HPLC  (Ismail et al., 2018). Table 2 shows recent 
publications used HPLC for direct chiral separation.  
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Table 2: Recent publications used high performance liquid chromatography (HPLC) 
for direct chiral separation 
Targets Samples CSPs Reference 
8 Anticholinergic drugs Standards 
(Racemic) 
Polysaccharide (Li et al., 2018) 
8 Bedaquiline analogue Standards 
(Racemic) 
Polysaccharide (Jiang et al., 
2019) 
Miconazole Standard 
(Racemic) 
Polysaccharide (Bounoua et al., 
2018) 
Active Pharmaceutical 
Ingredient (API) 
Salt Macrocyclic 
glycopeptide 
(Ismail et al., 
2018) 
Quinolones  Standard 
(Racemic) 
Teicoplanin 
Macrocyclic 
glycopeptide 
(Ali et al., 
2018) 
Propranolol, Atenolol, 
Metoprolol, Venlafaxine, 
Fluoxetine, and 
Amlodipine 
 
Standards 
(Racemic) 
Vancomycin  (Li et al., 2019) 
18 Synthetic Cathinones  Urine and 
Plasma  
Astec Cellulose DMP 
and Amylose-based 
Chiralpak AS-H 
(Meetani et al., 
2019) 
12 Isoxazolines 
Racemate  
Standards 
(Racemic) 
Pherphenylcarbamate 
cyclodextrin (CD)   
(Yang et al., 
2017) 
22 Basic Pharmaceutical 
Drugs  
Standards 
(Racemic) 
Vancomycin (Guo et al., 
2018) 
Substituted 1,3-
diazaspiro[4.5]decan-4-
ones 
Standard 
(Racemic) 
Polysaccharides  (Aboul-Enein et 
al., 2018) 
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Besides HPLC, CE has attracted the attention of many analytical chemists who 
work in the field of enantioseparation in recent years. CE separation is a microscale 
technique capable of separating chiral ionic compounds, such as amino acids. CE 
selectivity is based on the compound charge to size ratio (Prior et al., 2016). One of 
the most common CSP or chiral selector used for chiral CE is Cyclodextrins (CDs) 
such as β-Cyclodextrin (β-CD) Scheme 3. The differential interaction between the two 
enantiomers of a chiral compound with the chiral selector, such as CDs, causes 
differences in their overall electrophoretic migration resulting in their separation 
(Gübitz and Schmid, 2004). Table 3 shows recent publications used CE for direct 
chiral separation. 
 
Scheme 3: Chemical Structure of Cyclodextrin 
(Stick and Williams, 2009) 
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Table 3: Recent publications used Capillary Electrophoresis (CE) for direct chiral 
separation 
Targets Samples CSPs Reference 
Tramadol (TRA) 
and Methadone 
(MET) 
Tablets, Urine, 
and Plasma  
Maltodextrin (Naghdi and 
Fakhari, 2018) 
5 Acidic Drugs Raw material 
(Racemic 
samples) 
Streptomycin (Zhang et al., 
2017) 
Terbutaline and 
non-steroidal anti-
inflammatory drugs  
Raw material 
(Racemic 
samples) 
Lysine-Bridged 
Hemispherodextrin  
(Cucinotta et al., 
2017) 
Novel Psychoactive 
Substance (NPS) 
Standards 
(Racemic) 
(+) ‐18‐crown‐6‐
tetracarboxylic acid 
 
(Hägele and 
Schmid, 2018) 
Amphetamines and 
Ephedrine  
Seized material Highly sulfated‐γ‐
cyclodextrin (HS‐γ‐
CD)  
(Cui et al., 2018) 
Cetirizine  Standard 
(Racemic) 
Dual Selector system: 
Borate-glucose 
complexes and 
Sulfated-β-
cyclodextrin (S- β 
CD)  
 
(Švecová and 
Petr, 2019) 
Anti-Alzheimer and 
Antifungal drugs  
Standards 
(Racemic) 
Several modified 
cyclodextrin (CD): 
Highly sulfated α, γ 
CDs, hydroxyl 
propyl‐β‐CD, and 
Sulfobutyl ether‐β‐
CD 
 
(Abdel-Megied et 
al., 2018) 
Non-protein amino 
acid homocysteine  
Standard 
(Racemic) 
Cyclodextrins (α -β -
γ‐CD) 
(Greño et al., 
2018) 
3 Synthetic 
Cathinones 
Standards 
(Racemic 
mixtures) 
2-hydroxyethyl-β-
cyclodextrin  
(Nowak et al., 
2018) 
Rasagiline 
(Antiparkinsonian 
drug)  
Standard 
(Racemic) 
Sulfobutylether‐β‐
cyclodextrin  
(Szabó et al., 
2019) 
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1.5.2.2 Indirect Chiral Separation  
Enantioseparation of chiral compounds can be obtained by the indirect method 
using chiral derivatizing agent (CDA). Both the targeted chiral compound and CDA 
must have compatible and derivatizable functional groups in order to undergo the 
reaction and form two possible diastereisomers which can be separated using an achiral 
column (Ilisz et al., 2008). For example, the primary and secondary amines synthetic 
cathinones have a compatible site for derivatization with CDA by the removal of one 
acidic hydrogen of amine and formation of a new amide bond between the chiral 
compound and CDA. On the other hand, tertiary amines synthetic cathinones cannot 
be derivatized using the indirect method since they lack compatible sites for CDA. The 
resulted diastereisomers from the reaction of a chiral compound with CDA will interact 
differently with the achiral stationary phase (or column) and show at different retention 
times when using separation technique such as Gas Chromatography (GC) or Liquid 
Chromatography (LC). 
 Despite, the development of selective chiral chromatographic columns for 
chiral separation, many scientists prefer the use of CDA in GC and other separation 
techniques. The reasons are the availability and low cost of most of the CDA and the 
ability to use an achiral column to produce high resolution separation of the two 
corresponding enantiomers.   
1.5.3 Cathinones Chiral Separation using Gas Chromatography 
Gas chromatography (GC) hyphenated with mass spectrometry (MS) is one of 
the analytical technique used for chiral separations of synthetic cathinones (Alremeithi 
et al., 2018). GC-MS can perform direct and indirect chiral separation. The direct 
approach mainly performed on chiral stationary phase (CSPs) or column as a selector. 
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The indirect approach requires derivatization of the chiral compound using chiral 
derivatizing agents (CDA), then the resulted diastereisomers are separated on an 
achiral stationary phase or column (Camacho-Munoz et al., 2016).  
There are many commercially available derivatization agents used for the 
derivatization of alkaloids and amphetamine-like drugs using GC-MS such as (S)-(-)-
N-(Trifluoroacetyl)pyrrolidine-2-carbonyl chloride (L-TPC), see Scheme 4, (Weiß et 
al., 2015). 
             
 
Scheme 4: Chemical Structures of L-TPC and FLEC 
Alremeithi et al. recently reported an indirect chiral separation of thirty-six 
synthetic cathinone compounds using L-TPC as the chiral derivatizing agent in GC-
MS (Alremeithi et al., 2018).  
(±)-1-(9-fluorenyl)ethyl chloroformate (FLEC), see Scheme 4, is another well-
known CDA, used in for chiral separation of environmental and pharmaceutical 
relevant molecules (Moldovan et al., 2017). FLEC chiral derivatizing agent was used 
for separation and quantitative determination of β -Methylamino-L-alanine (BMAA) 
enantiomers. Derivatization of BMAA with FLEC prior to LC-MS/MS injection 
resulted in high resolution separation of D- and L- BMAA derivatives (Zurita et al., 
2019).  
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Another CDA called (1R)-(-)-menthylchloroformate (MCF) was used to 
achive chiral separation of many chiral compounds. MCF is consider cheap and readily 
available chiral derivatizing agent (Přech et al., 2013). The use of MCF as CDA for 
indirect chiral separation of novel amphetamine derivatives by GC-MS was reported 
recently (Weiß et al., 2017). The article compared menthylchloroformate with another 
CDA called (R)-(+)- α-methoxy- α-trifluoromethylphenylacetic acid (MTPA) and it 
was reported that menthylchloroformate was feasible to chirally separate few of the 
amphetamine derivatives, but with less satisfying resolution compared to MTPA. 
Scheme 5 shows the chemical structure of menthylchloroformate (MCF). 
 
 
Scheme 5: Chemical Structure of Menthylchloroformate (MCF) 
Menthylchloroformate (MCF) was used as CDA for rapid and simple chiral 
separation of natural and synthetic origin substituted Tetrahydroisoquinolines 
(THIQs). The developed method proved robustness where all THIQs diastereoisomers 
easily resolved with high resolution using achiral GC column (Přech et al., 2013). 
The use of menthylchloroformate (MCF) as CDA for chiral separation of 
synthetic cathinones using GC-MS or any other separation techniques is yet to be 
reported. Table 4 shows publications for indirect chiral separation using chiral 
derivatizing agents (CDAs). 
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Table 4: Indirect chiral separation using chiral derivatizing agents (CDAs) 
Targets Samples CDA Instrument  Reference 
Ketoprofen (KET) Saliva (S)-1-methyl-4-(5-(3-
aminopyrrolidin-1-
yl)-2,4-dinitro-
phenyl) piperazine 
(APy-PPZ)  
 
LC-MS/MS (Jin et al., 
2018) 
Methamphetamine Human 
oral fluids 
Marfey’s reagent (N-
(2,4-dinitro-5-
fluorophenyl)-L-
alaninamide) 
 
LC-MS/MS (Borg et 
al., 2018) 
Pregabalin  Standard 
(Racemic) 
(S) 
trifluoroacetylprolyl 
chloride ((s)-TPC) 
 
GC-MS (Hitchcoc
k and 
Marginean
, 2018) 
31 Synthetic 
Cathinones  
Human 
urine and 
plasma  
(S)-()-N-
(trifluoroacetyl)pyrrol
idine-2-carbonyl 
chloride (L-TPC)  
 
GC-MS (Alremeit
hi et al., 
2016) 
 
1.5.4 Quantitative Analysis of Synthetic Cathinones 
In forensic toxicology, it is important to perform qualitative and quantitative 
analysis to identify the type of illicit drug an abuser consumed and how much of it is 
presented in his or her biological samples such as blood or urine at the time of arrest. 
The quantitative analysis plays a major role in courts and law as it can determine the 
penalty for the abuser. In postmortem toxicology, quantitative analysis can provide 
information regarding the cause of death.  
In recent years, many qualitative and quantitative methods were developed by 
scientists using different analytical approaches. On the other hand, New Designer 
Drugs (NDD) such as synthetic cathinones have taken great attention from the 
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scientific community and forensic science due to their toxicity and rapid growth 
around the world. Unfortunately, many forensic laboratories do not have a 
comprehensive analytical screening method available for detection and quantitative 
determination of NDD in biological samples. The rapid growth and emerging of these 
types of drugs forces the forensic laboratory to continually modify their existing 
screening methods (Zuba and Adamowicz, 2018). 
Several analytical methods have been developed for the quantitative 
determination of synthetic cathinones in biological samples such as urine, blood and 
hair using gas chromatography coupled with mass spectrometry (GC-MS) or coupled 
with other detectors. On the other hand, there is a shortage in studies focusing on the 
quantitation of enantiomers of chiral drugs such as synthetic cathinones. In this thesis, 
a chiral quantitation method will be developed for synthetic cathinones determination 
in spiked urine samples after dervitization with menthylchloroformate as CDA using 
GC-MS. Table 5 shows developed methods for quantitative analysis of synthetic 
cathinones in biological materials using GC-MS. 
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Table 5: Synthetic cathinones analysis in biological materials using GC-MS  
 Targets Samples Purification Derivatization LOD Linear 
range 
Reference 
36 Synthetic 
cathinones 
Urine 
and 
plasma 
SPE  L-TPC 0.26 – 
0.34 
ppb 
1 – 
100 
ppb  
(Alremeit
hi et al., 
2018) 
6 Synthetic 
cathinones  
Urine  SPE  2,2,2-
Trichloroethyl 
chloroformate  
 
5 – 20 
ppb 
1 – 
1000 
ppb 
(Hong et 
al., 2015) 
18 Synthetic 
cathinones 
Urine Liquid – 
liquid 
extraction 
(LLE) 
Trifluoroaceti
c anhydride 
(TFAA)  
 
 
10 – 
30 ppb  
100 – 
1000 
ppb  
(Gerace et 
al., 2019) 
6 Synthetic 
cathinones 
and other 
NPSs 
Urine 
and 
blood 
SPE Pentafluoropr
opionic 
anhydride 
(PFPA)  
 
0.2- 
1.0 
ppb  
0.5 – 
50 ppb  
50 – 
2000 
ppb  
(Nisbet et 
al., 2019) 
22 Synthetic 
cathinones  
Urine  SPE Pentafluoropr
opionic 
anhydride 
(PFPA)  
 
0.5 – 
10 ppb  
50 – 
2000 
ppb  
(Alsenedi 
and 
Morrison, 
2018) 
 
1.5.4.1 Mass Spectrometry (MS) 
In this work, mass spectrometry (MS) was coupled with gas chromatography 
(GC) for the quantitative determination of synthetic cathinones. MS has grown rapidly 
in the past few decades with its applications in different scientific disciplines in both 
health and life science. MS works by the formation of ions (negatively or positively 
charged) in gas phase which can be separated magnetically or electrically based on 
their mass-to-charge ratio (m/z). The MS output or spectrum plots m/z vs. intensity 
which represents the analyzed compound ions and its corresponding fragmented ions.  
21 
 
 
 
 
MS can provide information regarding the composition, structure and the purity of the 
analyzed compound (El-Aneed et al., 2009). 
In addition, many scientists use the sequential mass spectrometry or sometimes 
called tandem mass spectrometry (MS/MS) instead of the single mass spectrometry 
(ms) instrument as an analytical detector. This technique applies the use of multiple 
quadrupole instruments which can do different tasks such mass selection of the 
targeted compound (precursor ion), further fragmentation of the targeted compound 
(product ions), and m/z analysis of the resulted ions (Dass, 2010). The process of 
fragmentation and ions activation occurs in the reaction region of the instrument via 
collision induced dissociation (CID). CID depends on natural gases such as helium, 
argon, or nitrogen to convert the translational energy of the targeted precursor ion into 
internal energy resulting in the formation of product ions of that precursor. The 
fragmentation intensity or pattern depends on the collision energy (high or low-energy) 
used in CID (Niessen, 2017). Using tandem MS substantially increases the sensitivity 
and selectivety of the analytical method especially with complex matrices (Portolés et 
al., 2012). 
In general, mass spectrometry (MS) consists of an ion source which produces 
gas phase ions, single or multiple mass analyzers to separate the ions based on their 
mass-to-charge ratio (m/z), and a detector. Ionization (ion formation) is considered the 
first step in MS analysis.There are common ion sources or ionization methods used in 
MS such as electron ionization (EI) source, chemical ionization (CI) source, and 
electrospray ionization (ESI) source. Electron impact ionization (EI) works by 
producing accelerated electrons capable of impacting the sample vapor (targeted 
molecules) resulting in the removal of one other electron from the molecule to form a 
radical cation [M+.]. The produced molecule cations can be further fragmented by 
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another impacting electron from the EI source. On the other hand, chemical ionization 
(CI) is considered a soft ionization technique compared to EI. It works by ionizing the 
ionization gas (such methane or ammonia) using accelerated electrons generated by a 
filament, followed by chemical interaction of the ionized gas with the sample 
molecules. Usually, a proton transfer is involved in CI. Moreover, ESI is another 
common source of ionization where a high voltage is used to convert the pumped 
analytical solution into ionized spray or small charged droplets. ESI is mainly used 
and easily interface the liquid chromatogram (LC) and the capillary electrophoresis 
(CE) with mass spectrometry (de Hoffmann, 2005).  
1.5.4.2 Negative Chemical Ionization (NCI) 
Chemical inonization (CI) is an ionization method used as a standard or 
optional feature in most commercially available mass spectrometry (MS) that can be 
performed using a wide range of reagent gases. The reagent gases such as methane, 
ammonia, and isobutane are used to generate positive or negative ion mass capable of 
chemically interacting and ionizing molecules of the targeted sample. Moreover, the 
resulted ions from the first interaction (collision) of the ion reagent with the molecules 
can undergo further ion/molecules reactions to produce higher order products. CI 
normally results in a less energetic (softer) ionization of the targted sample than 
electron ionization (EI). In addition, CI provides a higher sensitivity for quantitative 
analysis than EI (Westmore and Alauddin, 1986).  
One form of chemical ionization (CI) is the production of negative plasma ions 
by the CI source which have the ability to react with substrate molecules. This form of 
CI is called negative chemical ionization (NCI) that can be produced using series of 
reagent gases with the ability to produce quasi-molecular or molecular ions to analyze 
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compounds of medical, environmental, or biological interest. The gaseous molecules 
will be inonized inside the inoization source and interact with the anlayts to produce 
negative ions. NCI is a selective and sensitive technique for analytes capable of 
forming stable negative ions. Some of these well known reagents used in NCI are 
methane, ammonia, and isobutane (Budzikiewicz, 1986).  
 Among the different ionization sources, electron ionization (EI) has 
been the most used source of ionization in mass spectrometry (MS). EI is considered 
a hard ionization source and usually results in high and extensive fragmentation of the 
compound of interest which compromises the sensitivity of the analytical method. To 
overcome the EI disadvantages, softer ionization technique such as chemical 
ionization (CI) can be used to achieve better sensitivity, lower signal-to-noise (S/N) 
ratio, and overall enhancement in chromatographic and mass spectral signals (Portolés 
et al., 2012). For example, Húšková el al. had reported and compared the separation of 
pesticides in different matrices using GC-NCI-MS (gas chromatography-negative 
chemical ionization-mass spectrometry), GC-PCI-MS (gas chromatography-positive 
chemical ionization-mass spectrometry), and GC-EI-MS (gas chromatography-
electron impact ionization-mass spectrometry) systems. Methane was used as a reagent 
gas for the NCI. GC-NCI-MS system provided a better signal-to-noise ratio (S/N), and 
lower limit of detections (LODs) compared to both GC-PCI-MS and GC-EI-MS  
(Húšková et al., 2009). Another example is the use of GC-NCI-MS system by 
Alremeithi et al. for quantitative determination of synthetic cathinone enantiomers in 
urine and plasma. The article compares the obtained results of the study with a  
previously reported analytical method for quantitative determination of the same drugs 
using GC-EI-MS. Comparing the results using GC-NCI-MS method with GC-EI-MS, 
GC-NCI-MS showed an enhancement in the sensitivity by two orders of magnitude 
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(Alremeithi et al., 2018). Table 6 shows publications used negative chemical ionization 
(NCI).  
Table 6: Recent publications using negative chemical ionization (NCI)  
Targets Samples Instrument Reference 
Sugar phosphates  Cancer cell  GC-NCI-MS (Okahashi et al., 
2019) 
Pesticide Fruits and 
vegetables 
GC-NCI-MS (Besil et al., 2015) 
Trans-fatty acids  Human blood GC-NCI-MS (Kuiper et al., 
2018) 
10 Perfluorinated 
carboxylic acids  
Water GC-NCI-MS (Wang et al., 
2019) 
Synthetic cannabinoids Standards  GC-NCI-MS (Umebachi et al., 
2017) 
Non-steroidal anti-
inflammatory drugs 
(NSAIDs) 
 
Water GC-NCI-MS (Marsik et al., 
2017) 
Five kinds of banned 
drugs (two hormones, 
two sedatives, and one 
chloramphenicol) 
 
Milk powder  GC-NCI-MS (Wu et al., 2015) 
Psychoactive substance 
(MDPBP (1-(3,4-
methylenedioxyphenyl)-
2-(1-pyrrolidinyl)-1-
butanone))  
 
Postmortem 
human blood 
samples  
GC-NCI-MS (Wiergowski et al., 
2016) 
6 Cannabinoids and 
metabolites  
Oral fluids GC-NCI-MS (Desrosiers et al., 
2015) 
Testosterone (T) and 5α-
dihydrotestosterone 
(DHT)  
Spiked serum 
samples  
GC-NCI-MS (Kannenberg et al., 
2018) 
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1.5.4.3 Other Analytical Methods 
From the past few decades, new analytical techniques have been evolved to 
support the high demands for drugs discovery, development and anlaysis. As a result, 
these developed techniques provide accurate and precise detection and quantitation 
analysis for newly designed drug substances. Moreover, the developed analytical 
techniques play a very important role in the basis of designing highly efficient drugs, 
studying the degradation process of these drugs, and evaluating their quality 
(Ramachandra, 2017). 
Like many other synthetic drugs, synthetic cathinones have been causing 
serious social problems worldwide. In order to cope with the rapid changes in chemical 
structures of these new designer drugs (NDD), forensic scientists are continually 
modifying their exciting screening methods using different analytical approaches to 
detect and quantify those types of drugs in seized and biological materials. In addition 
to gas chromatography (GC), high performance liquid chromatography (HPLC) and 
capillary electrophoresis (CE) have been also used for analyzing synthetic cathinones 
in seized and biological materials (Fabregat-Safont et al., 2019) (Baciu et al., 2016).  
High performance liquid chromatography (HPLC) is among the most 
frequently used methods for chiral compounds separation. A high-resolution 
separation is usually obtained when using chiral stationary phases (CSPs) such as 
ligand-exchange-type CSPs, cyclodextrin-based CSPs, polyamide-based CSPs, 
polysaccharide-based CSPs, and protein-based CSPs (Okamoto and Ikai, 2008).  
An inexpensive method for chiral separation of 25 synthetic cathinones was 
developed using high performance liquid chromatography coupled with Ultraviolet 
detector (HPLC-UV). The developed method used achiral column with a mobile phase 
consists of methanol, water, and sulfated-β-cyclodextrin (S- β CD) (Taschwer et al., 
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2014).  Ambach et al. were able to separate and quantify 56 new psychoactive 
substances (NPSs) including synthetic cathinones in whole blood and urine using 
HPLC-MS/MS with a chiral column (Ambach et al., 2015). Table 7 shows recent 
published methods for quntitative analysis of synthetic cathinones in biological 
materials using high performance liquid chromatography (HPLC). 
Table 7: Synthetic cathinones analysis in biological materials using HPLC 
Targets Samples Purification Detector LOD Linear 
range 
Reference 
18 
Synthetic 
cathinones 
Urine 
and 
plasma 
SPE  HPLC-
UV-VIS 
1 – 1.47 
PPM  
0.14 – 
0.67 PPM 
5 – 250 
ppm 
(Meetani 
et al., 
2019) 
NPSs 
including 
cathinones  
Urine  SPE  HPLC-
MSMS 
0.01 – 2.3 
ppb 
1 – 
2000 
ppb 
(Borovcov
á et al., 
2018) 
22 
Synthetic 
cathinones 
Urine 
and 
blood 
SPE HPLC-
MSMS 
0.25 – 5 
ppb 
 
1 – 5 ppb  
5 – 
1000 
ppb  
(Glicksber
g et al., 
2016) 
4′-methyl-
α-
pyrrolidin
ohexanop
henone 
(MPHP) 
 
Urine  SPE HPLC-
MSMS 
0.5 ppb  1 – 100 
ppb  
 
(Shintani-
Ishida et 
al., 2016) 
16 NPSs 
including 
cathinones  
Blood  Micro-SPE 
And LLE 
LC-
MSMS 
0.2 ppb  5 – 500 
ppb  
(Montesan
o et al., 
2017) 
 
 
Capillary electrophoresis (CE) has also been a technique of choice for 
quantitative analysis of synthetic cathinones and other drugs (Merola et al., 2014). CE 
is considered a new technique compared to GC and LC, and it is usually used in 
analytical studies as a complementary tool for LC and GC. CE uses a small capillary 
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to separate charged analytes under the impact of an electric field. It has the advantages 
of short analysis time, smaller sample size (nano scale), and low running cost 
compared to GC and LC (Siddiqui et al., 2017). In addition, CE have been recently 
used for chiral separation of synthetic cathinones and other chiral compound using 
modified cyclodextrins as chiral selectors (Řezanková et al., 2018). For synthetic 
cathinones quantitative analysis, CE is usually coupled with mass spectrometry (MS) 
detector (Cui et al., 2018) or ultraviolet (UV) detector (Merola et al., 2014). Merola et 
al. have developed a rapid chiral separation of 12 synthetic cathinones using 
cyclodextrin-assisted capillary electrophoresis (CE) coupled with ultraviolet (UV) and 
mass spectrometry (MS) detectors. The conducted research provided high resolution 
separation of the targeted synthetic cathinones with detection limits down to 1.0 ppb 
were obtained (Merola et al., 2014). Recently, Nowak et al. have investigated eight 
cyclodextrins as potential chiral selectors for chiral separation of three commonly 
abused synthetic cathinones (ephedrone, mephedrone and metaphedrone) using CE 
equipped with a diode array detector (DAD). Among the different tested cyclodextrins, 
2-hydroxyethyl-β-cyclodextrin was reported to be the most efficient enantioselector 
for the targeted compounds (Nowak et al., 2018). As seen in Table 3, cyclodextrin 
derivatives are the most common chiral selectors used with capillary electrophoresis 
(CE).  
The work presented in this thesis describes research into the development of 
an analytical method for the analysis of ten (10) synthetic cathinones using gas 
chromatography tandem mass spectrometry (GC-MSMS) with negative chemical 
ionization (NCI) and multiple reaction monitoring (MRM) mode. The studied 
synthetic cathinones were converted into their two corresponding enantiomers after a 
reaction with menthylchloroformate (MCF) chiral derivatizing agent (CDA). A 
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racemic mixture of the ten synthetic cathinones was qualitativly and quantitativly 
analyzed in spiked urine samples as well as method validation. Scheme 6 shows the 
structure of the ten studied synthetic cathinones and the internal standard (IS) used in 
this thesis.  
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Scheme 6: Chemical Structures of the Ten Synthetic Cathinones and the Internal 
Standard (IS) 
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Chapter 2: Methods 
2.1 Chromatographic Condition 
Chromatographic separation was performed on an Agilent 7890A GC equipped 
with a 7693B autosampler and 7000 Series triple quadrupole (QQQ) mass 
spectrometer detector, MSD system (Agilent, USA). An Agilent Ultra Inert 60 m 
capillary column consisting of (5%-Phenyl)-methylpolysiloxane, with 0.25 mm inner 
diameter and a 0.25 µm film thickness was used as stationary phase. Chemical 
ionization (CI) with methane gas (40%, 2.0 mL/min) was employed in the negative 
ion mode at a voltage of 110 eV. Helium was used as carrier gas at a constant flow rate 
of 1.0 mL/min. An injection of 3 µL of sample solution was performed automatically 
in splitless mode. The injector and GC–MS interface line temperature were set at 250 
and 280 oC, respectively. Data collection was performed in Multiple Reaction 
Monitoring (MRM) mode as shown in Table 8 starting at 42 min after injection (i.e., 
filament delay). The column temperature program was as follows: starting at 160 oC 
and hold for 5 min, followed by heating to 270 oC with a heating rate of 2 oC/min. The 
final temperature was held at 270 oC for 5 min. 
The obtained data was analyzed using the Agilent Mass Hunter Workstation 
software B.06.00. 
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Table 8: Time segments table with selected fragments (ions) in MRM mode for the 
analysis of cathinones mixture 
Compound Name Abbreviation  Time  Precursor 
(m/z) 
Fragment 
(m/z) 
2-Fluoromethcathinone  2-FMC 44.00-
45.55 
363.5 212, 155 
2-Fluoroethcathinone  2-FEC 45.55-
47.20 
377.5 226, 155 
Buphedrone  -  
47.20-
49.00 
359.8 344, 212,  
3-Methymethcathinone  
(Internal Standard) 
3-MMC (IS) 359.5 155, 145 
4-Methylethcathinone 4-MEC  
 
49.00-
51.65 
373.8 344, 188, 
155 
3-Methylbuphedrone  3-MethylBP 373.8 212, 174  
2,4-Dimethylmethcathinone 2,4-DMMC  
 
51.65-
53.70 
373.5 217, 173 
4-Methyl- α-
ethylaminobutiophenone 
 
 
387.8 226, 155 
 
3,4-Dimethylethcathinone 3,4-DMEC 387.5 231, 188 
4-Bromoethcathinone 4-BMC 55.10-
58.00 
424.7 211, 81 
Butylone - 58.00-
65.00 
403.5 212, 190, 
175, 155 
 
 
Development of an acquisition method for the 7890A Series 
The procedure involves the following tasks:  
Task 1: Setting the inlet and injection parameters 
Task 2: Entering GC acquisition parameters 
Task 3: Creating an acquisition method to find precursor ions (Scan mode) 
Task 4: Acquiring precursor ion scan data  
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Task 5: Determining precursor ion masses  
Task 6: Creating an acquisition method to find product ions (Product scan mode)  
Task 7: Acquiring product ion scan data  
Task 8: Determining product ion masses 
Task 9: Creating the MRM method  
Task 10: Acquiring MRM data 
Task 11: Creating an MRM quantitative analysis method 
2.2 Chemicals and Reagents 
All chemicals were of analytical grade. Triethylamine, acetonitrile, methanol, 
2-propanol, hexane, dichloromethane, ammonium hydroxide, (1R)-(-)-
Menthylchloroformate 99% purity, and sodium phosphate were obtained from Sigma-
Aldrich Chemicals (St. Louis, MO, USA). Doubly deionized water was obtained from 
ultra-pure Millipore system (MS, USA). All synthetic cathinones standards shown in 
Table 2 were purchased from Cayman chemicals (Michigan, USA) by Dubai Police, 
Dubai and were kindly gifted to us. Synthetic cathinones standards used in this study 
were supplied as racemic mixtures of R and S enantiomers.  
2.3 Sample Preparation 
2.3.1 Samples 
 This work conforms to the UAE community guidelines for the use of humans' 
samples in experiments. 
2.3.2 Stock Solution 
 All synthetic cathinones samples were obtained in powdered form. For GC 
analysis, each sample was dissolved in 50 µL triethylamine and certain amount of 
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acetonitrile to obtain final concentration of 1000 ppm for each. Stock solutions were 
further diluted with acetonitrile to obtain the desired concentrations.  
2.3.3 Urine Spiking and Solid Phase Extraction (SPE) 
 Solid phase extraction (SPE) was carried manually and offline. Column was 
200MG clean screen CSDAU203 from FluoroChem, (Hadfield, UK). Urine sample 
was diluted with doubly deionized water in 1:1 ratio. 2 mL of diluted urine was spiked 
with 1 mL of 50 ppm synthetic cathinones mixture and internal standard (IS) 3-
Methylmethcathinone (3-MMC) in addition to 1 mL of 0.1 M phosphate buffer (pH 
6.0). The mixture was mixed and vortexed for 1 min. For SPE cartridge conditioning, 
1 mL of methanol and 1 mL of doubly deionized water were used.  2 mL of spiked 
urine sample was loaded to the cartridge followed by sequential washing using 1 mL 
0.1 M acetic acid and 1 mL methanol. The cartridge was left for drying under soft air 
stream for 1 min. Finally, 3 mL of the eluate mixture, which is made of 
dichloromethane, hexane, isopropanol, and ammonium hydroxide with a relative ratio 
of (39:39:20:2) was used to collect the analyte. The collected sample was evaporated 
to dryness under soft air stream.   
2.3.4 Derivatization Step 
 Derivatization reaction was done for the spiked urine samples after the 
evaporation step in SPE. The obtained dried and free of water sample was dissolved 
in 50 µL of triethylamine and 850 µL acetonitrile to obtain final concentration of 50 
ppm. 500 µL of the 50-ppm sample was reacted with 35 µL of menthylchloroformate 
CDA and vortex for 10 min at room temperature. The derivatized sample was stored 
in the freezer for 24 hrs. prior to injection in GC-MS instrument.  
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2.4 Method Validation 
 The adopted analytical approach and performance in this study was validated 
in terms of linearity, sensitivity (Limit of Detection (LOD), Limit of Quantitation 
(LOQ)), intraday and interday reproducibility, and recovery for all tested spiked urine 
samples. 
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Chapter 3: Results 
3.1 GC-MS/MS Database Development 
 The GC-MS/MS method was developed by creating a quantitative analysis 
method, which consist of the following steps: (1) precursor ions scanning and 
determination, (2) creation of acquisition data file for the determined precursor ions, 
(3) precursor ions fragmentation at different collision energies, (4) product ion 
determination for each compound, (5) determination of the most suitable collision 
energies, (6) MRM method creation. Table 9 shows the compound name, the 
determined precursor ion of each compound, the resulted product ions for each 
compound, the suitable collision energy and the retention time of each.  
Table 9: MRM acquisition parameter for the analysis of cathinones mixture in urine 
No Compound Time 
(min) 
Precursor 
Ion (m/z) 
Product 
Ion (m/z) 
Collision 
energy (v) 
Dwell 
Time (ms) 
1 2-FMC 44.00-
45.55 
363.5 212, 155 10,15,20,25 100 
2 2-FEC 45.55-
47.20 
377.5 226, 155 10,15,20,25 100 
3 Buphedrone  
47.20-
49.00 
359.8 344, 212, 
155, 145 
10,15,20,25 100 
IS 3-MMC 359.5 202, 188 10,15,20,25 100 
4 4-MEC  
49.00-
51.65 
373.8 344, 188, 
155 
10,15,20,25 100 
5 3-MethylBP 373.8 212, 174 10,15,20,25 100 
6 2,4-DMMC  
 
 
51.65-
53.70 
373.5 217, 173 10,15,20,25 100 
7 
 
4-Methyl- α-
ethylaminobutioph
enone 
387.8 226, 155 10,15,20,25 100 
8 3,4-DMEC 387.5 231, 188 10,15,20,25 100 
9 4-BMC 55.10-
58.00 
424.7 211, 81 10,15,20,25 100 
10 Butylone 58.00-
65.00 
403.5 212, 190, 
175, 155 
10,15,20,25 100 
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3.2 Cathinones Enantiomers Separation 
 One of the specific objectives of this research work is separate and convert 
each synthetic cathinone into two enantiomers using the pure chiral derivatizing agent, 
Menthylchloroformate (Scheme 7).  
 
Scheme 7: Derivatization Reaction between Cathinone and Menthylchloroformate  
The ten synthetic cathinones reacted with the derivatizing agent MCF. The 
reaction took place between the acid chloride in the derivatizing agent and the amine 
group of the targeted compound. Figure 1 shows the separation of the (R) and (S) 
enantiomers of Butylone drug after derivatization with MCF. 
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Figure 1: GC Chromatogram for separation of the R and S enantiomers of Butylone 
drug in acetonitrile after derivatization with MCF 
All ten tested compounds were derivatized using MCF under the same 
conditions. Each compound was analyzed individually on GC-NCI-MS using MRM 
mode. Table 10 shows the retention time, resolution values and selectivity factor of 
the separated enantiomers for the ten analyzed synthetic cathinones. 
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Table 10: List of the analyzed synthetic cathinones, internal standard and their 
synonyms, in addition to the retention times of the separated two enantiomers for 
each compound analyzed on GC-MS using MRM mode 
# Compound Name Abbreviation Time (min) Resolution Selectivity 
Factor (α) 
tR1 tR2 
1 2-Fluoromethcathinone  
 
2-FMC 44.75 45.13 2.95 1.008 
2 2-Fluoroethcathinone  
 
2-FEC 46.25 46.50 2.74 1.005 
3 Buphedrone  
 
- 47.40 47.75 2.89 1.007 
IS 3-Methylmethcathinone 3-MMC 58.75   
4 4-Methylethcathinone 
 
4-MEC 50.50 50.75 2.44 1.005 
5 3-Methylbuphedrone 
 
3-MethylBP 50.50 50.83 2.85 1.006 
6 2,4-
Dimethylmethcathinone 
 
2,4-DMMC 52.10 52.80 3.33 1.013 
7 4-Methyl- α-
ethylaminobutiophenone 
 
- 52.30 52.70 1.83 1.008 
8 3,4-Dimethylethcathinone 
 
3,4-DMEC 53.00 53.30 1.66 1.006 
9 4-Bromoethcathinone 
 
4-BMC 55.30 55.55 1.24 1.004 
10 Butylone 
 
- 61.40 61.75 2.60 1.007 
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Figure 2 shows the GC total ion chromatogram (TIC) for the analyzed synthetic 
cathinones mixture after being spiked in urine followed by SPE and derivatization step 
using MCF. A good separation can be observed of the mixture components. 
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Figure 2: Total Ion Chromatogram (TIC) of the simultaneous chiral separation of ten synthetic cathinone compounds. The mixture was spiked in 
urine and separated by MCF 
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GC chromatograms of compounds with similar retention time such as 4-MEC 
and 3-MethylBP, as shown in Figures 3 and 4 respectively, are obtained by extracting 
the specific chromatogram of each compound. In addition, 2,4-DMMC has one of its 
enantiomers overlapping with 4-Methyl- α-ethylaminobutiophenone in terms of 
retention time. 2,4-DMMC is extracted from the TIC as shown in Figure 5.  
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Figure 3: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 4-MEC  
A
b
u
n
d
an
ce
 
Time (min) 
4-MEC 
A
b
u
n
d
an
ce
 
  
43 
 
 
Figure 4: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 3-MethylBP 
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Figure 5: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 2,4-DMMC 
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Moreover, the rest of the separated synthetic cathinones were also extracted 
from the obtained total ion chromatogram (TIC) of the simultaneous chiral separation 
of the synthetic cathinones mixture spiked in urine for more accurate determination 
and quantitative analysis. Figures 6-12 shows the extracted ion chromatogram (EIC) 
for 2-FMC, 2-FEC, Buphedrone, 4-Methyl- α-ethylaminobutiophenone, 3,4-DMEC, 
4-BMC, and Butylone respectively.  
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Figure 6: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 2-FMC 
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Figure 7: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 2-FEC 
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Figure 8: Extracted Ion Chromatogram (EIC) of R and S enantiomers of Buphedrone 
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Figure 9: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 4-Methyl- α-ethylaminobutiophenone 
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Figure 10: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 3,4-DMEC 
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Figure 11: Extracted Ion Chromatogram (EIC) of R and S enantiomers of 4-BMC 
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Figure 12: Extracted Ion Chromatogram (EIC) of R and S enantiomers of Butylone 
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3.3 Method Validation 
 Method validation was performed on the ten analyzed compounds spiked in 
urine matrix. Method was validated in terms of calibration curve linearity, sensitivity 
(Limit of Detection (LOD), Limit of Quantitation (LOQ)), intraday and interday 
reproducibility, and spike recovery. 
 The calibration graphs for the ten enantiomer pairs of the synthetic cathinones 
were obtained in a linear form within the tested range of 0.5 to 50 ppm in urine with 
mean regression coefficient (R2; n=5) of 0.98 or higher. Figure 13 shows the 
calibration graphs of the two 2-FMC enantiomers in urine mixture.  
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a) 
 
b) 
 
 
Figure 13: Calibration graphs of the two separated enantiomers of 2-FMC compound 
spiked in urine obtained within 0.5-50 ppm range. a) E1 URINE b) E2 URINE  
The sensitivity of the method was validated in terms of limit of detection 
(LOD) and limit of the quantitation (LOQ) for the two separated enantiomers of each 
of the ten analyzed synthetic cathinone compounds in urine. Table 11 summarizes the 
regression coefficient, LOD and LOQ of the separated enantiomers of every analyzed 
compound in urine. 
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Table 11: Regression coefficient R2 values, limits of quantitation (LOQ) and limits of 
detection (LOD) for the ten synthetic cathinone compounds spiked in urine 
 
  R2 ± SD LOQ ± SD (ppm) LOD ± SD (ppm) 
 Name E1 E2 E1 E2 E1 E2 
1 2-FMC 
0.9893 ± 
0.0150 
0.9879 ± 
0.0150 
0.142 ± 
0.0021 
0.135 ± 
0.003 
0.047 ± 
0.0007 
0.045 ± 
0.0003 
2 2-FEC 
0.9896± 
0.0227 
0.9827 ± 
0.0285 
0.062 ± 
0.0004 
0.063 ± 
0.0003 
0.020 ± 
0.0003 
0.021 ± 
0.0001 
3 Buphedrone 
0.9924 ± 
0.1133 
0.9921 ± 
0.1560 
0.013 ± 
0.0005 
0.012 ± 
0.0004 
0.004 ± 
0.0002 
0.004 ± 
0.0004 
4 4-MEC 
0.9939 ± 
0.1055 
0.9929 ± 
0.1027 
0.030 ± 
0.0032 
0.028 ± 
0.0003 
0.010 ± 
0.0010 
0.009 ± 
0.0001 
5 3-MethylBP 
0.9938 ± 
0.0049 
0.9917 ± 
0.0060 
0.347 ± 
0.0002 
0.621 ± 
0.0681 
0.114 ± 
0.0009 
0.205 ± 
0.0224 
6 2,4-DMMC 
0.9906 ± 
0.0010 
0.9939 ± 
0.0023 
2.493 ± 
0.0007 
1.878 ± 
0.0005 
0.823 ± 
0.0002 
0.620 ± 
0.0002 
7 
4-Methyl- α-
ethylaminobutiophe
none 
0.9973 ± 
0.0077 
0.9904 ± 
0.0129 
0.421 ± 
0.0171 
0.222 ± 
0.0030 
0.139 ± 
0.0006 
0.073 ± 
0.0011 
8 3,4-DMEC 
0.9937 ± 
0.0002 
0.9912 ± 
0.0008 
9.536 ± 
0.3699 
3.429 ± 
0.0160 
3.147± 
0.1221 
1.131 ± 
0.0528 
9 4-BMC 
0.9912 ± 
0.0618 
0.9904 ± 
0.0389 
0.059 ± 
0.0014 
0.089 ± 
0.0009 
0.019 ± 
0.0005 
0.029± 
0.0003 
10 Butylone 0.9886 ± 
0.0354 
0.9935 ± 
0.0413 
0.094 ± 
0.0010 
0.091 ± 
0.0013 
0.031 ± 
0.0002 
0.030 ± 
0.0004 
 
For the accuracy and reproducibility validation of this study, intraday and 
interday reproducibility were obtained by testing two different concentration levels 
(10 ppm and 25 ppm) for the two separated enantiomers of each of the ten analyzed 
synthetic cathinone compounds in urine as shown in Table 12. For intraday, each of 
the two concentration levels was run twice in the same day and the same concentration 
levels were run twice on the second day for interday reproducibility. The 
reproducibility results were obtained in terms of coefficient of variance for the ten 
analyzed synthetic cathinone compounds in urine.  
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Table 12: Intraday and interday reproducibility results for the ten synthetic cathinone 
compounds spiked in urine at two different concentration levels for the two 
enantiomers of each compound 
  CV% Intraday CV% Interday 
  10 ppm 25 ppm 10 ppm 25 ppm  
  E1 E2 E1 E2 E1 E2 E1 E2 
1 2-FMC 1.40 2.40 2.56 2.09 2.33 3.18 4.77 2.40 
2 2-FEC 3.77 0.89 1.01 2.97 7.75 3.22 3.71 6.14 
3 Buphedrone 3.15 2.74 1.73 1.23 3.68 4.77 6.33 2.92 
4 4-MEC 6.71 2.61 1.36 4.56 9.77 7.41 2.57 7.29 
5 3-MethylBP 4.03 1.15 2.22 3.70 12.24 6.62 4.52 10.16 
6 2,4-DMMC 2.57 2.33 4.82 5.93 3.63 2.69 9.85 10.33 
7 
4-Methyl- α-
ethylaminobutiophe
none 
6.27 4.36 1.21 2.49 9.35 6.21 4.81 7.83 
8 3,4-DMEC 3.60 7.77 6.30 2.13 4.57 9.68 7.04 4.66 
9 4-BMC 1.71 1.95 1.38 2.40 3.45 3.98 1.64 4.88 
10 Butylone 2.56 1.29 1.45 1.19 2.85 1.29 2.82 1.94 
 
 For the recovery study, an evaluation of the percent error has been done for the 
spiked mixture in urine at two different concentration levels (10 ppm and 25 ppm) as 
shown in Table 13. 
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Table 13: Recovery measurements expressed in percent errors for the ten synthetic 
cathinone compounds spiked in urine at two different concentration levels for the 
two enantiomers of each compound 
  Error % 
  10 ppm 25 ppm 
  E1 E2 E1 E2 
1 2-FMC 2.36 6.23 8.77 11.57 
2 2-FEC 3.07 4.46 5.19 4.12 
3 Buphedrone 5.14 6.23 8.77 11.70 
4 4-MEC 7.52 3.69 3.64 4.91 
5 3-MethylBP 3.34 5.72 4.04 4.88 
6 2,4-DMMC 4.98 3.74 7.41 9.09 
7 
4-Methyl- α-
ethylaminobutiophenone 
9.57 2.64 7.92 10.64 
8 3,4-DMEC 5.19 6.76 8.46 4.17 
9 4-BMC 2.39 3.14 2.29 4.98 
10 Butylone 3.95 2.86 3.91 2.98 
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Chapter 4: Discussion 
This study adopts the indirect chiral separation method using 
Menthylchloroformate (MCF) as a chiral derivatizing agent (CDA). MCF reacted with 
secondary amine enantiomers of the ten analyzed synthetic cathinone derivatives 
resulting in two corresponding diastereoisomers of each of the ten compounds. The 
resulted diastereoisomers from the reaction of synthetic cathinones with MCF 
interacted differently with the achiral stationary phase column and were presented in 
different retention time on the gas chromatography (GC) chromatogram. All ten 
analyzed synthetic cathinone compounds (Table 8) have been derivatized by MCF and 
the interaction resulted in the formation of a two-unique corresponding enantiomers of 
each of the ten analyzed compounds. The total ion chromatogram (TIC) of the 
synthetic cathinones mixture spiked in urine showed different corresponding pairs of 
enantiomers with different resolutions and intensity of the products. This difference is 
suggested to be caused by the difference of physicochemical properties such as 
stereochemistry and stability of the analyzed compound on the achiral column. 
Moreover, the structure difference, the distance between the two asymmetric centers 
in the substrate and CDA, and the conformational rigidity around the chiral center 
might influence the difference in resolution and intensity of the resulted corresponding 
enantiomers (Toyo’oka, 2002). Using the Multiple Reaction Monitoring (MRM) mode 
for the collection of data, it was possible to separate the ten analyzed synthetic 
cathinone compounds simultaneously in one chromatogram after spiking them in urine 
(Figure 2). The obtained TIC (Figure 2) had two synthetic cathinone compounds 
sharing the similar retention time 4-MEC and 3-MethylBP. By extracting the specific 
chromatogram of each of the two compounds, it was possible to determine and 
quantify them separately (Figures 3 and 4). In addition, one compound (2,4-DMMC) 
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had one of its enantiomers overlapping with 4-Methyl- α-ethylaminobutiophenone in 
terms of retention time. It was possible to determine and quantify the compound by 
extracting its exact ion chromatogram (EIC). In addition, the rest of the separated 
synthetic cathinones were also extracted from the obtained TIC for more accurate 
determination and quantitative analysis. Calibration curves of the ten analyzed 
synthetic cathinone compounds in urine were constructed based on the two 
corresponded enantiomers peak areas of each compound in the tested range (0.5 to 50 
ppm). 3-Methylmethcathinone (3-MMC) was added as an internal standard (IS) to the 
ten analyzed synthetic cathinones mixture. 3-MMC was chosen due to its similar 
structure to the studied synthetic cathinone compound and its good reactivity with 
MCF. 3-MMC was previously investigated and its reaction with MCF resulted in the 
formation of one peak. This formation of one peak can be explained as that the 3-MMC 
compound we have is a pure (R) or (S) enantiomer or one of the enantiomers has a 
higher reactivity with MCF compared to the other. Figure 13 shows the calibration 
graphs of the two separated enantiomers of 2-FMC compound spiked in urine. All 
constructed graphs showed linearity and good correlation coefficient (R2) values 
higher than 0.98 as shown in Table 11. Table 11 also shows the Limits of Quantitation 
(LOQ) and Limits of Detection (LOD) values for each enantiomer for the ten analyzed 
synthetic cathinone compounds mixture spiked in urine. For LOQ in urine, the range 
was 0.012 – 9.536 ppm and for LOD the range was 0.004 – 3.147 ppm. Both LOQ and 
LOD were measured based on signal-to-noise (S/N) method (Shrivastava and Gupta, 
2011). 
Intraday and interday reproducibility of the ten analyzed synthetic cathinones 
mixture were evaluated and reported at two different concentration levels (10 and 25 
ppm) as shown in Table 12. For intraday, each of the two concentration levels was run 
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twice in the same day and the same concentration levels were run twice on the second 
day for interday reproducibility. The method reproducibility was evaluated based on 
the coefficient of variance values and all the analyzed enantiomers showed values 
below 12.3% in urine suggesting a good reproducibility of the adopted method.  
For the evaluation of the adopted solid phase extraction (SPE), the method 
recovery has been studied by calculating the percent error for the ten analyzed 
synthetic cathinones mixture in urine at two different concentrations (10 and 25 ppm). 
The percent error values were within the acceptable range for most of the enantiomers 
in urine.  
4.1 Data Comparison 
 Alremeithi et al. have recently published a research article titled “Simultaneous 
Quantitative Determination of Synthetic Cathinone Enantiomers in Urine and Plasma 
Using GCI-NCI-MS”. They were able to indirectly separate 36 synthetic cathinone 
compounds using (S)-(-)-N-(Trifluoroacetyl) pyrrolidine-2-carbonyl chloride (L-TPC) 
as chiral derivatizing agent (CDA). In addition, 14 synthetic cathinones were 
quantitatively determined after being spiked in urine and plasma followed by 
derivatization step using L-TPC (Alremeithi et al., 2018). Among the 14 synthetic 
cathinones in Alremeithi et al. article, four synthetic cathinones including Buphedrone, 
3-MethylBP, 3,4-DMEC, and Butylone were studied in this research work. Those four 
compounds were compared in both studies in terms of LOQs and LODs as shown in 
Table 14.  
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Table 14: LOQs and LODs Data Comparison  
Presented Thesis (Alremeithi et al., 2018) 
 
 LOQ (ppm) LOD (ppm) LOQ (ppm) LOD (ppm) 
Name E1 E2 E1 E2 E1 E2 E1 E2 
1 Buphedrone 0.013  0.012  0.013  0.012  9.6x10-4  9.2x10-4   2.9x10-4   2.8x10-4   
2 3-MethylBP 0.347  0.621  0.347  0.621  1.02x10-3 9.9x10-4   3.1x10-4   3.0x10-4 
3 3,4-DMEC 9.536  3.429  9.536  3.429  1.12x10-3 1.39x10-3 3.410-4 4.2x10-4 
4 Butylone 0.094  0.091  0.094  0.091  8.6x10-4   9.8x10-4 2.610-4 2.7x10-4 
 
As shown in Table 14 above, Alremeithi et al. results show better sensitivity in 
terms of LOQs and LODs for the four synthetic cathinones. In addition, the adopted 
method using L-TPC as CDA showed better separation (baseline separation) for most 
of the analyzed compounds compared to our results. Both studies (this work and 
Alremeithi et al.) have used GC-NCI-MS and the main difference was the type of chiral 
derivatizing agent used.   
We were expecting to obtain better results in terms of resolutions, LOQs, and 
LODs by using menthylchloroformate (MCF) as chiral derivatizing agent (CDA). Due 
to the use of only one bottle of MCF from one source (manufacture), it is possible that 
the purity of MCF had affected the overall reaction with the targeted synthetic 
cathinone compounds. Moreover, the derivatization reaction took place under 
controlled anhydrous condition due to high reactivity of MCF with water and to 
maximize the reaction efficiency. Despite the adequate care given to minimize any 
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possible experimental errors, there are still errors (random or systematic) such as 
instrumental setup, samples purity, derivatizing agent reactivity, extraction efficiency 
and recovery might affect the overall experimental design. 
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Chapter 5: Conclusion 
A sensitive and selective analytical method for separation and quantitative 
determination of synthetic cathinones in urine using gas chromatography tandem mass 
spectrometry (GC-MSMS) was successfully developed. The developed method adopts 
the indirect chiral separation technique using menthylchloroformate (MCF) as chiral 
derivatizing agent. A mixture of ten synthetic cathinones was spiked in urine followed 
by solid phase extraction (SPE) and derivatization using MCF. 3-
Methylmethcathinone (3-MMC) was used as an internal standard (IS) in synthetic 
cathinones quantitation due to similar structure to the analyzed compounds. The ten 
derivatized synthetic cathinones mixture in urine were separated as their optical 
enantiomers successfully using a 60 m achiral stationary phase column in GC. 
Calibration curves of the ten analyzed synthetic cathinones in urine were constructed 
based on the two corresponded enantiomers peak areas of each compound in the tested 
range (0.5 to 50 ppm). The analytical method was validated in terms of calibration 
curve linearity, LOQ, LOD, intraday and interday reproducibility, and spike recovery 
for all ten synthetic cathinones mixture spiked in urine. It was found that LOQs and 
LODs of the ten synthetic cathinones in urine were in the ranges of 0.012 – 9.536 ppm 
and 0.004 – 3.147 ppm respectively.  
5.1 Recommendations 
The following are recommendation for possible future work to extend this study: 
• Applying this analytical method for the detection and quantitative 
determination of other synthetic cathinones which have not yet analyzed.  
• Comparing different derivatizing agents such as L-TPC, MCF, and MTPA for 
indirect chiral separation of synthetic cathinone compounds. 
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• Using chiral stationary phase column in GC for separation of synthetic 
cathinone compounds (direct chiral separation) instead of using CDA (indirect 
chiral separation). 
• Comparing different gases in the negative chemical ionization (NCI) source 
such as isobutene, ammonia, argon and a mixture of methane and ammonia 
(95:5). 
• Comparing negative chemical ionization (NCI) with other ionization 
techniques such positive chemical ionization (PCI), and electron impact 
ionization (EI) for quantitative determination of synthetic cathinones. 
• Using other biological matrices such as plasma or saliva for the detection and 
quantitative determination of synthetic cathinones. 
• Comparing GC-MS with other analytical techniques used for chiral separation 
of synthetic cathinones such as HPLC-MS, HPLC-UV, and CE-UV. 
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Appendix 
 
 
 
Figure 14: Calibration curves of 2-FEC enantiomers in urine 
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Figure 15: Calibration curves of Buphedrone enantiomers in urine 
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Figure 16: Calibration curves of 4-MEC enantiomers in urine 
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Figure 17: Calibration curves of 3-MethylBP enantiomers in urine 
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Figure 18: Calibration curves of 2,4-DMMC enantiomers in urine 
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Figure 19: Calibration curves of 4-Methyl- α-ethylaminobutiophenone enantiomers 
in urine 
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Figure 20: Calibration curves of 3,4-DMEC enantiomers in urine 
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Figure 21: Calibration curves of 4-BMC enantiomers in urine 
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Figure 22: Calibration curves of Butylone enantiomers in urine 
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